This is the authors' abstract. We don't add key points for this paper.
Some decision-making in medicine is easy. Facilitated by clear guidance, powerful evidence and strong opinion we can often reassure our patients that a therapeutic choice is the right one. Things are not so easy in the arena of older persons oncology where the evidence base thins and attitudes to the outcomes that are most important vary significantly. Balancing risks and benefits becomes trickier. The use of chemotherapy for older adults is fraught with the dangers of undertreating those incorrectly judged to be frail and overtreating those not recognised as pre-frail.1 A good decision requires a careful judgement of patient fitness and attitude which is best achieved by the Comprehensive Geriatric Assessment (CGA).2 A CGA done well and done right requires expertise, multidisciplinarity and crucially, time. The ‘Comprehensive’ of the title is the most important clue.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Simcock et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: